Literature DB >> 14762133

Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors.

Lin Pei1, Frank J S Lee, Anna Moszczynska, Brian Vukusic, Fang Liu.   

Abstract

Functional interactions between dopamine D1-like receptors and NMDA subtype glutamate receptors have been implicated in the maintenance of normal brain activity and neurological dysfunction. Although modulation of NMDA receptor functions by D1 receptor activation has been the subject of extensive investigation, little is known as to how the activation of NMDA receptors alters D1 function. Here we report that NMDA receptors regulate D1 receptor function via a direct protein-protein interaction mediated by the carboxyl tail regions of both receptors. In both cotransfected cells and cultured hippocampal neurons the activation of NMDA receptors increases the number of D1 receptors on the plasma membrane surface and enhances D1 receptor-mediated cAMP accumulation via a SNARE-dependent mechanism. Furthermore, overexpression of mini-genes encoding either NR1 or D1 carboxyl tail fragments disrupts the D1-NR1 direct protein-protein interaction and abolishes NMDA-induced changes in both D1 cell surface expression and D1-mediated cAMP accumulation. Our results demonstrate that the D1-NR1 physical interaction enables NMDA receptors to increase plasma membrane insertion of D1 receptors and provides a novel mechanism by which the activation of NMDA receptors upregulates D1 receptor function. Understanding the molecular mechanisms by which D1 and NMDA receptors functionally interact may provide insight toward elucidating the molecular neurobiological mechanisms involved in many neuropsychiatric illnesses, such as schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14762133      PMCID: PMC6793575          DOI: 10.1523/JNEUROSCI.3922-03.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  58 in total

1.  Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons.

Authors:  W Lu; H Man; W Ju; W S Trimble; J F MacDonald; Y T Wang
Journal:  Neuron       Date:  2001-01       Impact factor: 17.173

2.  Effects of the D-1 agonist SKF-38393 combined with haloperidol in schizophrenic patients.

Authors:  M Davidson; P D Harvey; R L Bergman; P Powchik; R Kaminsky; M F Losonczy; K L Davis
Journal:  Arch Gen Psychiatry       Date:  1990-02

3.  Effects of NMDA receptor antagonists on D1 dopamine receptor-mediated changes in striatal immediate early gene expression: evidence for involvement of pharmacologically distinct NMDA receptors?

Authors:  K A Keefe; A Ganguly
Journal:  Dev Neurosci       Date:  1998       Impact factor: 2.984

4.  Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit.

Authors:  M D Ehlers; S Zhang; J P Bernhadt; R L Huganir
Journal:  Cell       Date:  1996-03-08       Impact factor: 41.582

5.  Calcium-dependent inactivation of recombinant N-methyl-D-aspartate receptors is NR2 subunit specific.

Authors:  J J Krupp; B Vissel; S F Heinemann; G L Westbrook
Journal:  Mol Pharmacol       Date:  1996-12       Impact factor: 4.436

Review 6.  The neurobiology of slow synaptic transmission.

Authors:  P Greengard
Journal:  Science       Date:  2001-11-02       Impact factor: 47.728

Review 7.  Schizophrenia and glutamatergic transmission.

Authors:  C A Tamminga
Journal:  Crit Rev Neurobiol       Date:  1998

8.  Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor.

Authors:  M Hollmann; J Boulter; C Maron; L Beasley; J Sullivan; G Pecht; S Heinemann
Journal:  Neuron       Date:  1993-05       Impact factor: 17.173

9.  Differential modulation by dopamine of responses evoked by excitatory amino acids in human cortex.

Authors:  C Cepeda; Z Radisavljevic; W Peacock; M S Levine; N A Buchwald
Journal:  Synapse       Date:  1992-08       Impact factor: 2.562

10.  Insulin stimulates sequestration of beta-adrenergic receptors and enhanced association of beta-adrenergic receptors with Grb2 via tyrosine 350.

Authors:  V Karoor; L Wang; H Y Wang; C C Malbon
Journal:  J Biol Chem       Date:  1998-12-04       Impact factor: 5.157

View more
  72 in total

1.  Proteomic analysis of native metabotropic glutamate receptor 5 protein complexes reveals novel molecular constituents.

Authors:  Carol D Farr; Philip R Gafken; Angela D Norbeck; Catalin E Doneanu; Martha D Stapels; Douglas F Barofsky; Manabu Minami; Julie A Saugstad
Journal:  J Neurochem       Date:  2004-10       Impact factor: 5.372

2.  Mosaic parental germline mutations causing recurrent forms of malformations of cortical development.

Authors:  Julia Lauer Zillhardt; Karine Poirier; Loïc Broix; Nicolas Lebrun; Adrienne Elmorjani; Jelena Martinovic; Yoann Saillour; Giuseppe Muraca; Juliette Nectoux; Bettina Bessieres; Catherine Fallet-Bianco; Stanislas Lyonnet; Olivier Dulac; Sylvie Odent; Imen Rejeb; Lamia Ben Jemaa; Francois Rivier; Lucile Pinson; David Geneviève; Yuri Musizzano; Nicole Bigi; Nicolas Leboucq; Fabienne Giuliano; Nicole Philip; Catheline Vilain; Patrick Van Bogaert; Hélène Maurey; Cherif Beldjord; François Artiguenave; Anne Boland; Robert Olaso; Cécile Masson; Patrick Nitschké; Jean-François Deleuze; Nadia Bahi-Buisson; Jamel Chelly
Journal:  Eur J Hum Genet       Date:  2015-09-23       Impact factor: 4.246

3.  Allosteric changes of the NMDA receptor trap diffusible dopamine 1 receptors in spines.

Authors:  Lena Scott; Sergey Zelenin; Seth Malmersjö; Jacob M Kowalewski; Eivor Zettergren Markus; Angus C Nairn; Paul Greengard; Hjalmar Brismar; Anita Aperia
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

Review 4.  Glutamate and GABA receptors and transporters in the basal ganglia: what does their subsynaptic localization reveal about their function?

Authors:  A Galvan; M Kuwajima; Y Smith
Journal:  Neuroscience       Date:  2006-10-23       Impact factor: 3.590

5.  Intrastriatal dopamine D1 antagonism dampens neural plasticity in response to motor cortex lesion.

Authors:  E J H Davis; C Coyne; T H McNeill
Journal:  Neuroscience       Date:  2007-02-27       Impact factor: 3.590

6.  Inhibition of the dopamine D1 receptor signaling by PSD-95.

Authors:  Jingping Zhang; Angel Vinuela; Mark H Neely; Penelope J Hallett; Seth G N Grant; Gregory M Miller; Ole Isacson; Marc G Caron; Wei-Dong Yao
Journal:  J Biol Chem       Date:  2007-03-16       Impact factor: 5.157

Review 7.  Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance.

Authors:  Melissa L Perreault; Ahmed Hasbi; Brian F O'Dowd; Susan R George
Journal:  Neuropsychopharmacology       Date:  2013-06-18       Impact factor: 7.853

8.  Neurotoxicity of HIV-1 Tat protein: involvement of D1 dopamine receptor.

Authors:  Janelle M Silvers; Marina V Aksenova; Michael Y Aksenov; Charles F Mactutus; Rosemarie M Booze
Journal:  Neurotoxicology       Date:  2007-07-22       Impact factor: 4.294

9.  Activation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortex.

Authors:  Yan-Chun Li; Dong Xi; Joy Roman; Yue-Qiao Huang; Wen-Jun Gao
Journal:  J Neurosci       Date:  2009-12-09       Impact factor: 6.167

10.  Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia.

Authors:  Jubao Duan; Maria Martinez; Alan R Sanders; Cuiping Hou; Naruya Saitou; Takashi Kitano; Bryan J Mowry; Raymond R Crowe; Jeremy M Silverman; Douglas F Levinson; Pablo V Gejman
Journal:  Am J Hum Genet       Date:  2004-08-24       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.